In announcing its “Great Healthcare Plan” in January 2026, the Trump administration became the latest in a long history of efforts by the U.S. government to rein in the soaring cost of healthcare.

As a physician and professor studying the intersection of business and health, I know that the challenges in reforming the sprawling U.S. healthcare system are immense. That’s partly for political and even philosophical reasons.

But it also reflects a complex system fraught with competing interests—and the fact that patients, hospitals, health insurance companies, and drug manufacturers change their behaviors in conflicting ways when faced with new rules.

Soaring costs

U.S. healthcare is the most expensive in the world, and according to a poll published in late January 2026, two-thirds of Americans are very worried about their ability to pay for it—whether it’s their medications, a doctor’s visit, health insurance or an unpredictably costly medical emergency.

Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP

Privacy PolicyFast Company Newsletters

Disputes over health policy even played a central role in the federal government shutdown in fall 2025.

Trump’s healthcare framework outlines no specific policy actions, but it does establish priorities to address a number of longtime concerns, including prescription drug costs, price transparency, lowering insurance premiums, and making health insurance companies generally more accountable.

Why have these challenges been so difficult to address?

© Fast Company